BackGuangdong Marubi Biotechnology , Ltd. Overview

Guangdong Marubi Biotechnology , Ltd. Inventory

Track Guangdong Marubi Biotechnology , Ltd.'s inventory ($200M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$196.59M
↓ 18.46% YoYΔ $-44.51M vs prior year quarter

Peer trimmed avg / median

Loading

Guangdong Marubi Biotechnology , Ltd. Inventory History

Loading

Guangdong Marubi Biotechnology , Ltd. vs. peers: Inventory Comparison

Loading

Guangdong Marubi Biotechnology , Ltd. Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Guangdong Marubi Biotechnology , Ltd. (603983.SS) FAQ

As of the most recent data (June 2026), 603983.SS shows a inventory of $200M. That compares with $240M in the prior-year period — down 18.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 603983.SS's inventory is now $200M (was $240M) — a 18.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Guangdong Marubi Biotechnology , Ltd. is outperforming or lagging.

Tracking 603983.SS's inventory over time shows whether Guangdong Marubi Biotechnology , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $200M That compares with $240M in the prior-year period — down 18.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Guangdong Marubi Biotechnology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $200M) with ownership activity and broader fundamentals.